Chemotherapy in cancer patients with Covid-19 ‘not a risk’
Continuing chemotherapy and immunotherapy treatment in cancer patients with Covid-19 is not a risk to their survival, a study suggests. It also recommends further research into the drug hydroxychloroquine, which appeared to benefit some patients. The findings, from 890 infected cancer patients in the UK, Spain, Italy and Germany, could help identify who is most… Read More »